Rebus Biosystems: Neil Kennedy, Scott Kothlow

Spatial omics technology firm Rebus Biosystems announced the appointments of Neil Kennedy as chief commercial officer and Scott Kothlow as chief financial officer.

Kennedy will lead commercialization of Rebus' Esper platform, including sales, marketing, product management, and customer success. Kennedy brings 25 years of commercial experience, most recently as senior VP of commercial operations at Dovetail Genomics.

Kothlow brings 30 years of financial experience in the life sciences industry. He was previously CFO at Somalogic.